These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17927878)

  • 1. [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma].
    Jiao Y; Ban KC; Cao J; Yue HY; Luo Y; Su JJ
    Ai Zheng; 2007 Oct; 26(10):1085-9. PubMed ID: 17927878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma.
    Ban KC; Singh H; Krishnan R; Seow HF
    Cancer Lett; 2003 Sep; 199(2):201-8. PubMed ID: 12969793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
    Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIN1 gene overexpression and beta-catenin gene mutation/expression in hepatocellular carcinoma and their significance.
    Wang H; Zhang J; Feng W; Zhang S; Liang H; Wang Y; Zheng Q; Li Z
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):54-7. PubMed ID: 17393110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people.
    Cui J; Zhou X; Liu Y; Tang Z
    J Cancer Res Clin Oncol; 2001 Sep; 127(9):577-81. PubMed ID: 11570580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
    Kondo Y; Kanai Y; Sakamoto M; Genda T; Mizokami M; Ueda R; Hirohashi S
    Jpn J Cancer Res; 1999 Dec; 90(12):1301-9. PubMed ID: 10665646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China.
    Cui J; Zhou XD; Liu YK; Tang ZY; Zile MH
    World J Gastroenterol; 2001 Aug; 7(4):542-6. PubMed ID: 11819825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.
    Okabe H; Kinoshita H; Imai K; Nakagawa S; Higashi T; Arima K; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Ishiko T; Yoshizumi T; Beppu T; Monga SP; Baba H; Maehara Y
    PLoS One; 2016; 11(4):e0152695. PubMed ID: 27100093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma.
    Du GS; Wang JM; Lu JX; Li Q; Ma CQ; Du JT; Zou SQ
    Ann Surg Oncol; 2009 Jun; 16(6):1578-86. PubMed ID: 19290490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
    Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma.
    Jiang Y; Zhou XD; Liu YK; Wu X; Huang XW
    World J Gastroenterol; 2002 Oct; 8(5):804-7. PubMed ID: 12378619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
    Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
    J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
    Lin ZZ; Jeng YM; Hu FC; Pan HW; Tsao HW; Lai PL; Lee PH; Cheng AL; Hsu HC
    BMC Cancer; 2010 Aug; 10():461. PubMed ID: 20799978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.